Deans' stroke musings: Enzyme provides built-in protection against atherosclerosis

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, July 5, 2015

Enzyme provides built-in protection against atherosclerosis

How is your doctor fixing your atherosclerosis?
http://www.mdlinx.com/internal-medicine/medical-news-article/2015/07/01/6216664/?

University of Michigan Health System, 07/01/2015

New research suggests enzyme CD39 capable of clearing plaque that leads to heart attacks, strokes. Staying active, never smoking and controlling diabetes and cholesterol can prevent hardening of the arteries, but effective treatment of atherosclerosis could come down to harnessing an enzyme already built in to the blood vessels. In a new study published online ahead of print in the August issue of The Journal of Clinical Investigation, scientists at the University of Michigan Health System used mice to show that a human membrane–bound enzyme called CD39, which can clear the dangerous buildup of adenosine triphosphate (ATP) from the bloodstream, significantly reduces atherosclerosis in mice. The enzyme is known for its ability to control blood clots and reduce inflammation, but the study led by Yogen Kanthi, M.D., and David Pinsky, M.D., is the first to reveal a major role of CD39 in reducing atherosclerosis.